Dr. Michael Stojanovic is a board-certified orthopedic surgeon who joined OrthoNebraska in 2023 as a fellowship-trained knee and hip replacement surgeon. Dr. Stojanovic emphasizes patient-centered practices, successful outcomes, and improvement in patient quality of life. Through a collaborative approach with his patients and attention to detail, he and his staff ensure the utmost care surrounding all joint replacement procedures. He provides a breadth of techniques including muscle-sparing knee replacement, minimally-invasive total joint replacement, direct anterior hip replacement, partial knee replacement, and robotic-assisted hip and knee replacement in both the primary and revision setting.
Hometown: Dundee, IL
Conditions
Hip Arthritis, Hip Bursitis, Hip Dislocation, Hip Dysplasia, Hip Fractures, Knee Arthritis, Osgood-Schlatter Disease, Patellofemoral Pain Syndrome (Runner’s Knee), and less common conditions
Treatments
Hip Injections , Hip Replacement , Hip Replacement Revision Surgery , Knee Injections , Knee Replacement , Knee Replacement Revision Surgery , and less common treatments
Specialized Services
Specialized Services: Robotic-Assisted Knee Replacement, Same Day Joint Replacement, Opioid-Sparing Joint Replacement, Anterior Hip Replacement, Computer-Assisted Hip Replacement
Ages treated: Knees 45+, Hips 40+
Accepts workers comp: Yes
Team Members
Athletic Trainer
Credentials
Certifications
- Board Certified in Orthopaedic Surgery by the American Board of Orthopaedic Surgery
Education
- Northshore Orthopaedic Institute | Total Joint Replacement Fellowship, 2022
- University of Minnesota | Orthopedic Surgery Residency, 2021
- Penn State Hershey Medical Center | General Surgery Internship, 2016
- Loyola University Chicago | Doctorate in Medicine, 2015
- Marquette University | BS, 2011 (Biomechanical Engineering)
Memberships & Awards
- American Academy of Orthopaedic Surgeons
- Mid-America Orthopaedic Association
- American Association of Hip and Knee Surgeons
Patient Reviews
4.8 out of 5 (649 Ratings, 200 Comments)